Life Science Expertise

Unparalleled Experience and Expertise in Real Estate for the Life Science Industry

Since its founding in 1994, Alexandria has supported the life science industry by consistently being at the forefront of life science industry trends.

Alexandria Venture Investments: Supporting Companies Transforming the Lives of Patients

Founded in 1996, Alexandria Venture Investments is the company's strategic venture capital arm. Alexandria Venture Investments provides long-term strategic investment capital to innovative life science and technology entities developing breakthrough technologies and therapies. 

Leveraging our experience and in-depth understanding of the life science and technology industries, our long-term relationships with leading investors, and our world-class scientific advisory network, we are uniquely positioned to fund seed-, early-, and growth-stage companies.  

Areas of Focus 

  • Biopharma

  • Diagnostics

  • Research Tools

  • AgTech

  • Technology

Track Record

  • #1 Most Active Early-Stage Biopharma Investor by Deal Volume in 2017-1H18, as recognized by Silicon Valley Bank
  • $957M Total Book Value (as of September 30, 2018)
  • 140+ Direct Private Investments
  • 33 IPO Exits between 2013 and 2017
  • 10 M&A Exits between 2013 and 2017


Innovative Proprietary Products for the Life Science Industry

In addition to Alexandria's core business of build-to-suit campuses with office and Labspace® for the biopharmaceutical industry, Alexandria has developed a range of innovative products specifically designed for entrepreneurial life science companies and leading venture capitalists:

Accelerator® Life Science Partners

  • A revolutionary corporate and venture-backed vehicle for identifying, evaluating, financing, and managing entrepreneurial and innovative clinical and development life science opportunities

AgTech Accelerator™

  • A unique startup accelerator vehicle focused on discovering and developing emerging agricultural technology companies

Alexandria LaunchLabs®

  • Affordable, plug-and-play, fully integrated real estate platform providing flexible, full-service life science laboratory/office space, shared equipment and services, specialized amenities, and administrative support

Alexandria Science Hotel®

  • Fully flexible, built-out office/laboratory suites offering a full range of operational and service amenities purposefully designed for high-quality, early- and growth-stage life science companies

Alexandria Innovation Center®

  • State-of-the-art, highly collaborative facility providing mature science and technology companies with unique services designed to promote productivity and growth


  • High-end, flexible office suites for leading venture capitalists in Alexandria’s AAA urban clusters


Fostering Life Science Collaboration within our Real Estate

Design Expertise: At Alexandria, we have conducted extensive research on how design can foster meaningful life science collaboration. Within our properties, we strategically place collision spaces that are designed to spur your employees and the broad life science community to converge, exchange ideas, and advance knowledge.

Thought Leadership: In addition to developing world-class real estate for the life science industry, Alexandria brings together its global network to discuss and debate the most important global life science issues in meetings, conferences, and forums. One of our major efforts is the Alexandria Summit®, a groundbreaking meeting series where thought leaders from the pharmaceutical and biotechnology industry, medical, academic, financial, philanthropic, advocacy, and government come together to tackle the most critical global healthcare challenges shaping the future of life science R&D.

Sample Alexandria Summit participants include:

  • Tim Anderson, MD, Global Pharmaceuticals Analyst, Sanford C. Bernstein & Co., LLC
  • Tony Coles, MD, Chairman & Chief Executive Officer, Yumanity Therapeutics
  • Francis S. Collins, MD, PhD, Director, National Institutes of Health
  • Mikael Dolsten, MD, PhD, President, Worldwide Research and Development, Pfizer Inc.
  • Jean-Francois Formela, MD, MBA, Partner, Atlas Venture LP
  • Margaret Hamburg, MD, Former Commissioner, U.S. Food and Drug Administration
  • Robert J. Hugin, Former Executive Chairman & Chief Executive Officer, Celgene Corporation
  • John Mendelsohn, MD, Past-President, MD Anderson; Director, the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy 
  • James H. Simons, PhD, Chairman, Simons Foundation
  • Marc Tessier-Lavigne, PhD, President, Stanford University
  • Craig Thompson, MD, President & Chief Executive Officer, Memorial Sloan Kettering Cancer Center

» Learn more about the Alexandria Summit


Impactful Partnerships

On October 29-30, 2018, Robin Hood held its annual Investors Conference in Manhattan. As an integral part of Alexandria’s ongoing partnership with Robin Hood, Joel S. Marcus served as a member of the conference organizing committee, curating and moderating a conference discussion focused on the critical need for agricultural innovation to provide more nutritious food in order to feed a rapidly growing population, which is imperative to advancing human health.